Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Xi-An, China Clinical Trials

A listing of Xi-An, China clinical trials actively recruiting patients volunteers.

RESULTS

Found (4) clinical trials

Helicobacter Pylori Eradication With Different Bismuth Quadruple Therapies

The study will include three phases: screening, treatment and follow-up.Screening:this phase will last a maximum of 28 days and subjects eligibility will be evaluated after informed consent signature. Endoscopy and Urea Breath test will be performed in addition to the baseline routine evaluations.Treatment:Subjects are randomly assigned to treatment and will …

Phase

4.99 miles

Learn More »

TPM Regimen (Thalidomide Prednisone and Methotrexate) in LGLL

Because LGLL has continuously activated cytotoxic T lymphocytes, immunosuppressive therapy is the standard first-line therapy for T-LGLL and CLPD-NK. Previous studies showed that the overall response rate (ORR) of first-line oral immunosuppressants ranged from 21% to 85% (median: 50%). Both methotrexate and cyclosporine A are LGLL first-line treatment options, but …

Phase

8.16 miles

Learn More »

A Study of TQB2450 in Subjects With Stage III Non-Small Cell Lung Cancer(NSCLC)

This study is a randomized, double-blind, double-dummy,placebo parallel controlled, multi-centre,phase III clinical trial to evaluate the efficacy and safety of TQB2450 with or without anlotinib compared with placebo as consolidation treatment in subjects with locally advanced/unresectable (Stage III) Non-Small Cell Lung Cancer that has not progressed after prior concurrent/sequential chemoradiotherapy.

Phase

8.16 miles

Learn More »

Precision Therapy in Complex High-risk Coronary Artery Disease

This is a prospective registry to enroll complex high-risk coronary heart disease patients. The purpose of this study is to compare intracoronary physiology and imaging-guided intervention strategy and angiography-guided intervention strategy for clinical outcomes and health economics.

Phase N/A

9.49 miles

Learn More »